PDF herunterladen
Am J Perinatol 2021; 38(10): 1036-1041
DOI: 10.1055/s-0040-1701508
Original Article

Umbilical Blood Levels of IL-6 and TNF-α as Predictors of the Central Nervous System Damage and Retinopathy in Preterm Infants

Daiva Bartkevičienė
1   Department of Neonatology, Centre of Obstetrics and Gynecology, Clinic of Obstetrics and Gynecology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
,
Ingrida Pilypienė
1   Department of Neonatology, Centre of Obstetrics and Gynecology, Clinic of Obstetrics and Gynecology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
,
Danielius Serapinas 
2   Department of Psychology, Institute of Psychology, Mykolas Romeris University, Vilnius, Lithuania
3   Department of Family Medicine, Lithuanian University of Health Sciences, Kaunas, Lithuania
,
Brigita Vaigauskaitė
1   Department of Neonatology, Centre of Obstetrics and Gynecology, Clinic of Obstetrics and Gynecology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
,
Rasa Aurelija Vankevičiūtė
4   Department of Dermatovenereology, Clinic of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
,
Agnė Bartkevičiūtė
4   Department of Dermatovenereology, Clinic of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
,
Ieva Narkevičiūtė
5   Department of Immunology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
,
Irena Dumalakienė
5   Department of Immunology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
› Institutsangaben Funding Immunological studies of cord blood samples were funded by the Lithuanian State Science and Studies Foundation (2008–04–07 No. T-101/08).
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Objective The aim was to identify the critical levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and vascular endothelial growth factor-A in umbilical cord blood that could be used as markers for predicting the central nervous system (CNS) damage and retinopathy of prematurity (ROP) in preterm infants.

Study Design A total of 158 preterm infants, born at 22 to 34 weeks of gestation, were evaluated in the first week after birth and at 36 to 37 weeks of postconceptual age.

Results A significant relationship between CNS changes and concentrations of IL-6 (p < 0.001) and TNF-α (p < 0.001) in umbilical cord blood at 22 to 34 weeks of gestation was determined. The concentration of IL-6 >13.0 pg/mL predicts significant CNS damages in 36 to 37-week infants (p = 0.013). ROP was diagnosed in 24.8% infants (n = 149). It was detected that the levels of TNF-α >116.4 pg/mL (p < 0.001) and IL-6 >13.0 pg/mL (p < 0.05) in umbilical cord blood could predict 2 to 3/3 to 4 stages of ROP.

Conclusion Critical values of IL-6 and TNF-α in predicting ≥grade III intraventricular hemorrhage in the early adaptation and in predicting marked CNS damages and severe ROP stages in the later adaptation of preterm infants were determined.

Keywords

prematurity - cytokines - umbilical cord blood - intraventricular hemorrhage - retinopathy of prematurity


Publikationsverlauf

Eingereicht: 23. Juli 2019

Angenommen: 29. Dezember 2019

Artikel online veröffentlicht:
12. Februar 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Malaeb S, Dammann O. Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol 2009; 24 (09) 1119-1126
    CrossrefPubMedGoogle Scholar
  • 2 Black RE, Cousens S, Johnson HL. et al; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375 (9730): 1969-1987
    CrossrefPubMedGoogle Scholar
  • 3 Pappas A, Kendrick DE, Shankaran S. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr 2014; 168 (02) 137-147
    CrossrefPubMedGoogle Scholar
  • 4 Boyle EM, Poulsen G, Field DJ. et al. Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study. BMJ 2012; 344: e896
    CrossrefPubMedGoogle Scholar
  • 5 Swamy GK, Ostbye T, Skjaerven R. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 2008; 299 (12) 1429-1436
    CrossrefPubMedGoogle Scholar
  • 6 Matthiesen L, Kalkunte S, Sharma S. Multiple pregnancy failures: an immunological paradigm. Am J Reprod Immunol 2012; 67 (04) 334-340
    CrossrefPubMedGoogle Scholar
  • 7 Lockwood CJ, Murk WK, Kayisli UA. et al. Regulation of interleukin-6 expression in human decidual cells and its potential role in chorioamnionitis. Am J Pathol 2010; 177 (04) 1755-1764
    CrossrefPubMedGoogle Scholar
  • 8 Kuin RA, Vis JY, Mol BW. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients. Obstet Gynecol 2010; 115 (01) 186-187
    CrossrefPubMedGoogle Scholar
  • 9 Pilypienė I, Drazdienė N, Dumalakienė I. et al. The significance of fetal inflammatory response syndrome in early and later adaptation of premature infants. Arch Gynecol Obstet 2015; 291 (01) 67-72
    CrossrefPubMedGoogle Scholar
  • 10 Peirovifar A, Gharehbaghi MM, Gharabaghi PM, Sadeghi K. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity. Singapore Med J 2013; 54 (12) 709-712
    CrossrefPubMedGoogle Scholar
  • 11 Al-Abdullah AA, Kozak I. Toward better evidence: meta-analysis of vascular endothelial growth factor (VEGF) polymorphisms in retinopathy of prematurity. Saudi J Ophthalmol 2014; 28 (04) 251-252
    CrossrefPubMedGoogle Scholar
  • 12 Malik MA, Shukla S, Azad SV, Kaur J. Vascular endothelial growth factor (VEGF-634G/C) polymorphism and retinopathy of prematurity: a meta-analysis. Saudi J Ophthalmol 2014; 28 (04) 299-303
    CrossrefPubMedGoogle Scholar
  • 13 Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983; 103 (02) 273-277
    CrossrefPubMedGoogle Scholar
  • 14 International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123 (07) 991-999
    CrossrefPubMedGoogle Scholar
  • 15 McAdams RM, Juul SE. The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int 2012; 2012: 561494
    CrossrefPubMedGoogle Scholar
  • 16 Berger I, Peleg O, Ofek-Shlomai N. Inflammation and early brain injury in term and preterm infants. Isr Med Assoc J 2012; 14 (05) 318-323
    PubMedGoogle Scholar
  • 17 Yuan T-M, Sun Y, Zhan C-Y, Yu H-M. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and toll-like receptor signaling. J Neuroimmunol 2010; 229 (1-2): 16-25
    CrossrefPubMedGoogle Scholar
  • 18 Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol 2009; 87 (04) 264-280
    CrossrefPubMedGoogle Scholar
  • 19 Liu J, Feng Z-C. Increased umbilical cord plasma interleukin-1 beta levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J Trop Pediatr 2010; 56 (03) 178-182
    CrossrefPubMedGoogle Scholar
  • 20 Adén U, Favrais G, Plaisant F. et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010; 24 (05) 747-758
    CrossrefPubMedGoogle Scholar
  • 21 Goepfert AR, Andrews WW, Carlo W. et al. Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. Am J Obstet Gynecol 2004; 191 (04) 1375-1381
    CrossrefPubMedGoogle Scholar
  • 22 Bueter W, Dammann O, Leviton A. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res 2009; 66 (05) 487-494
    CrossrefPubMedGoogle Scholar
  • 23 Kuypers E, Ophelders D, Jellema RK, Kunzmann S, Gavilanes AW, Kramer BW. White matter injury following fetal inflammatory response syndrome induced by chorioamnionitis and fetal sepsis: lessons from experimental ovine models. Early Hum Dev 2012; 88 (12) 931-936
    CrossrefPubMedGoogle Scholar
  • 24 Pérez-Muñuzuri A, Fernández-Lorenzo JR, Couce-Pico ML, Blanco-Teijeiro MJ, Fraga-Bermúdez JM. Serum levels of IGF1 are a useful predictor of retinopathy of prematurity. Acta Paediatr 2010; 99 (04) 519-525
    CrossrefPubMedGoogle Scholar
  • 25 Woo SJ, Park KH, Jung HJ. et al. Effects of maternal and placental inflammation on retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2012; 250 (06) 915-923
    CrossrefPubMedGoogle Scholar
  • 26 Chen ML, Allred EN, Hecht JL. et al; ELGAN Study. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci 2011; 52 (10) 7052-7058
    CrossrefPubMedGoogle Scholar
  • 27 Li ML, Hsu SM, Chang YS. et al. Retinopathy of prematurity in southern Taiwan: a 10-year tertiary medical center study. J Formos Med Assoc 2013; 112 (08) 445-453
    CrossrefPubMedGoogle Scholar
  • 28 Chen M, Citil A, McCabe F. et al. Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity. Neonatology 2011; 99 (02) 125-132
    CrossrefPubMedGoogle Scholar
  • 29 Woo SJ, Park KH, Lee SY. et al. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. Invest Ophthalmol Vis Sci 2013; 54 (05) 3434-3439
    CrossrefPubMedGoogle Scholar
  • 30 Dammann O, Brinkhaus MJ, Bartels DB. et al. Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev 2009; 85 (05) 325-329
    CrossrefPubMedGoogle Scholar
  • 31 Sood BG, Madan A, Saha S. et al; NICHD neonatal research network. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 2010; 67 (04) 394-400
    CrossrefPubMedGoogle Scholar
  • 32 Costagliola C, Romano V, De Tollis M. et al. TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm 2013; 2013: 629529
    CrossrefPubMedGoogle Scholar
  • 33 Chapouly C, Tadesse Argaw A, Horng S. et al. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. Brain 2015; 138 (Pt 6): 1548-1567
    CrossrefPubMedGoogle Scholar
  • 34 Yang D, Baumann JM, Sun YY. et al. Overexpression of vascular endothelial growth factor in the germinal matrix induces neurovascular proteases and intraventricular hemorrhage. Sci Transl Med 2013; 5 (193) 193ra90
    CrossrefPubMedGoogle Scholar
  • 35 McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol 2008; 35 (04) 777-792 , vii
    CrossrefPubMedGoogle Scholar
  • 36 Yenice O, Cerman E, Ashour A. et al. Serum erythropoietin, insulin-like growth factor 1, and vascular endothelial growth factor in etiopathogenesis of retinopathy of prematurity. Ophthalmic Surg Lasers Imaging Retina 2013; 44 (06) 549-554
    CrossrefPubMedGoogle Scholar
  • 37 Hellgren G, Löfqvist C, Hård AL. et al. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity. Pediatr Res 2016; 79 (1-1): 70-75
    CrossrefPubMedGoogle Scholar
  • 38 Goswami B, Goyal M, Beri S, Garg R, Saili A, Jain A. Role of serum levels of vascular endothelial growth factor and its receptor in retinopathy of prematurity. Iran J Pediatr 2015; 25 (04) e2373
    CrossrefPubMedGoogle Scholar
  • 39 Zhu D, Chen C, Shi W. Variations of vascular endothelial growth factor and pigment epithelial-derived factor are related to the retinopathy of prematurity in human babies. West Indian Med J 2015; 65 (02) 251-255
    PubMedGoogle Scholar
  • 40 Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246 (10) 1467-1475
    CrossrefPubMedGoogle Scholar
  • 41 Klufas MA, Chan RV. Intravitreal anti-VEGF therapy as a treatment for retinopathy of prematurity: what we know after 7 years. J Pediatr Ophthalmol Strabismus 2015; 52 (02) 77-84
    CrossrefPubMedGoogle Scholar
  • 42 Morin J, Luu TM, Superstein R. et al; Canadian Neonatal Network and the Canadian Neonatal Follow-Up Network Investigators. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 2016; 137 (04) e20153218
    CrossrefPubMedGoogle Scholar